Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-08T13:19:20.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:54:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T22:38:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial, while adding new identifiers and a revision number.
    Difference
    19%
    Check dated 2025-04-16T15:28:19.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T10:53:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Stomach Cancer while removing references to Ovarian Cancer. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    0.2%
    Check dated 2025-04-01T23:43:18.000Z thumbnail image

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.